Brief: Kiniksa Pharmaceuticals Reports Fourth Quarter And Full-Year 2021 Results

Kiniksa Pharmaceuticals International

22/02/2022 13:35

Feb 22 (Reuters) - Kiniksa Pharmaceuticals Ltd  KNSA.O :
    * KINIKSA PHARMACEUTICALS REPORTS FOURTH QUARTER AND
FULL-YEAR
2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * SEES FY REVENUE $115 MILLION TO $130 MILLION
    * QTRLY  LOSS PER SHARE $0.53

Source text for Eikon:  ID:nGNX89jkMs 
Further company coverage:  KNSA.O 

 ((reuters.briefs@thomsonreuters.com;))